Nannan Liu

787 total citations
23 papers, 425 citations indexed

About

Nannan Liu is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Nannan Liu has authored 23 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Nannan Liu's work include Cancer-related Molecular Pathways (2 papers), Bone health and treatments (2 papers) and Hepatitis C virus research (2 papers). Nannan Liu is often cited by papers focused on Cancer-related Molecular Pathways (2 papers), Bone health and treatments (2 papers) and Hepatitis C virus research (2 papers). Nannan Liu collaborates with scholars based in China, Canada and United Kingdom. Nannan Liu's co-authors include Yingying Song, Youhua Xie, Yufeng Yao, Feifei Wang, Li Shi, Menghui Liu, Lingling Zhang, Jing Liu, Dan Tan and Yang Yang and has published in prestigious journals such as Blood, Scientific Reports and Expert Systems with Applications.

In The Last Decade

Nannan Liu

22 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nannan Liu China 10 149 90 86 65 53 23 425
Min Guan China 12 228 1.5× 124 1.4× 80 0.9× 67 1.0× 30 0.6× 28 532
Long-Tao Yue China 15 204 1.4× 82 0.9× 117 1.4× 87 1.3× 142 2.7× 25 553
Akinao Okamoto Japan 11 144 1.0× 160 1.8× 30 0.3× 38 0.6× 36 0.7× 31 417
Hyeon‐Gun Jee South Korea 11 276 1.9× 85 0.9× 55 0.6× 47 0.7× 40 0.8× 24 470
Xiaoqin Zheng China 13 156 1.0× 41 0.5× 35 0.4× 34 0.5× 74 1.4× 27 397
Maysam Mard‐Soltani Iran 11 175 1.2× 106 1.2× 53 0.6× 35 0.5× 72 1.4× 30 381
Huijun Zhu China 12 286 1.9× 109 1.2× 34 0.4× 57 0.9× 115 2.2× 32 501
Anna Sałkowska Poland 13 146 1.0× 68 0.8× 74 0.9× 22 0.3× 152 2.9× 24 390
Timo Siitonen Finland 16 229 1.5× 131 1.5× 65 0.8× 78 1.2× 74 1.4× 48 572
Kishu Ranjan United States 12 219 1.5× 47 0.5× 106 1.2× 69 1.1× 101 1.9× 21 482

Countries citing papers authored by Nannan Liu

Since Specialization
Citations

This map shows the geographic impact of Nannan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nannan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nannan Liu more than expected).

Fields of papers citing papers by Nannan Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nannan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nannan Liu. The network helps show where Nannan Liu may publish in the future.

Co-authorship network of co-authors of Nannan Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Nannan Liu. A scholar is included among the top collaborators of Nannan Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nannan Liu. Nannan Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kyle, Alastair H., et al.. (2024). DNA-PK inhibitor AZD7648 is a more portent radiosensitizer than PARP inhibitor Olaparib in BRCA1/2 deficient tumors. DNA repair. 139. 103689–103689. 2 indexed citations
2.
Liu, Nannan, et al.. (2023). ACO-KELM: Anti Coronavirus Optimized Kernel-based Softplus Extreme Learning Machine for classification of skin cancer. Expert Systems with Applications. 232. 120719–120719. 9 indexed citations
3.
Liu, Nannan, Shuqiong Zhang, Lei Shi, et al.. (2023). Transporter Associated with Antigen Processing 1 Gene Polymorphisms Increase the Susceptibility to Tuberculosis. Pharmacogenomics and Personalized Medicine. Volume 16. 325–336. 3 indexed citations
4.
Niu, Gaoli, Hong Wang, Xuejiao Xing, et al.. (2023). Penpulimab and Anlotinib in an Elderly Patient with Recurrent Cervical Cancer: A Case Report and Literature Review. Immunotherapy. 15(12). 905–912. 2 indexed citations
5.
6.
Kang, Ning, et al.. (2022). Proscillaridin A induces mitochondrial damage and autophagy in pancreatic cancer and reduces the stability of SMAD4 in Panc-1 cells. Annals of Translational Medicine. 10(15). 820–820. 3 indexed citations
7.
Song, Yingying, Huimin Guo, Nannan Liu, et al.. (2022). Establishment and characterization of a new cell culture system for hepatitis B virus replication and infection. Virologica Sinica. 37(4). 558–568. 5 indexed citations
8.
Liu, Nannan, Leiming Guo, Chuchu Zhang, et al.. (2022). Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway. International Journal of Biological Sciences. 18(6). 2419–2438. 14 indexed citations
9.
10.
Yu, Rongguo, Jiayu Zhang, Hong Xu, et al.. (2021). ARG2, MAP4K5 and TSTA3 as Diagnostic Markers of Steroid-Induced Osteonecrosis of the Femoral Head and Their Correlation With Immune Infiltration. Frontiers in Genetics. 12. 691465–691465. 17 indexed citations
11.
Liu, Menghui, Yang Yang, Kang Ning, et al.. (2021). Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates. Frontiers in Microbiology. 12. 626553–626553. 80 indexed citations
12.
Li, Qiuli, Nannan Liu, Xinhua Pan, et al.. (2021). HDACi Targets IKZF1 Deletion High-Risk Acute Lymphoblastic Leukemia By Inducing IKZF1 Expression and Rescuing IKZF1 Function in Vitro and In Vivo. Blood. 138(Supplement 1). 514–514. 3 indexed citations
13.
Yao, Yufeng, et al.. (2019). Influence of ERAP1 and ERAP2 gene polymorphisms on disease susceptibility in different populations. Human Immunology. 80(5). 325–334. 34 indexed citations
14.
Zhao, Jian, Nannan Liu, Shaohua Gou, et al.. (2019). Light-activated ruthenium (II)-bicalutamide prodrugs for prostate cancer. Journal of Inorganic Biochemistry. 196. 110684–110684. 18 indexed citations
15.
Huang, Yuan, Nannan Liu, Jing Liu, et al.. (2019). Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA. Cell Cycle. 18(24). 3442–3455. 64 indexed citations
16.
Wang, Hong, Shutu Xu, Nannan Liu, et al.. (2018). Beyond pathways: genetic dissection of tocopherol content in maize kernels by combining linkage and association analyses. Plant Biotechnology Journal. 16(8). 1464–1475. 56 indexed citations
17.
Zhou, Weiwei, Hongwei Wang, Nannan Liu, et al.. (2015). Diagnosis of Malignancy of Adult Mediastinal Tumors by Conventional and Transesophageal Echocardiography. Chinese Medical Journal. 128(8). 1047–1051. 4 indexed citations
18.
Liang, Xiangyan, Jian‐Kang Chen, Yufeng Zhao, et al.. (2011). Effect of Feining on bleomycin-induced pulmonary injuries in rats. Journal of Ethnopharmacology. 134(3). 971–976. 29 indexed citations
19.
Liu, Nannan, et al.. (2010). [Clinical analysis of 355 patients with bone metastasis of malignant tumors].. PubMed. 32(3). 203–7. 4 indexed citations
20.
Shaw, Antony N., Rosanna Tedesco, Ramesh Bambal, et al.. (2009). Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters. 19(15). 4350–4353. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min Guan Breakdown of academic impact, for papers by Long-Tao Yue Breakdown of academic impact, for papers by Akinao Okamoto Breakdown of academic impact, for papers by Hyeon‐Gun Jee Breakdown of academic impact, for papers by Xiaoqin Zheng Breakdown of academic impact, for papers by Maysam Mard‐Soltani Breakdown of academic impact, for papers by Huijun Zhu Breakdown of academic impact, for papers by Anna Sałkowska Breakdown of academic impact, for papers by Timo Siitonen Breakdown of academic impact, for papers by Kishu Ranjan
Rankless by CCL
2026